We Can Stop Melanoma

At DermTech, we believe we can help end deaths from melanoma in the near future. And we are working with patients, doctors, and other healthcare professionals to bring that promise to life.

We believe this because we have the tools to make it happen. The most effective way to eliminate melanoma deaths is to catch the disease early, and the DermTech Melanoma Test rules out early-stage melanoma correctly over 99% of the time. With a test that can be easily and quickly performed at your doctor’s office, or remotely under your doctor’s supervision. Our goal is to turn this belief into reality. And make melanoma a disease of the past.

“Someone in my life had a delayed melanoma diagnosis and ultimately succumbed to the disease — a disease that, as an M.D., I know is very treatable when caught early. I saw an opportunity to create a better approach to melanoma detection and potentially save lives.”

— John Dobak, M.D.

President and CEO of DermTech

Meet the team that is defining the new era of precision dermatology with innovation, entrepreneurship, passion, and personal experience.

Meet Our Leaders

John Dobak, M.D.

President and CEO

» Read Bio

Kevin Sun

Chief Financial Officer

» Read Bio

Claudia Ibarra

Chief Operating Officer

» Read Bio

Todd Wood

Chief Commercial Officer

» Read Bio

Meet Our Boards

Our Board of Directors

Our Board of Directors has diverse experience in biotechnology, diagnostics, therapeutics, medical and other industries, bringing decades of experience to the team. 

» Meet Our Board of Directors

Our Scientific Advisory Board

Our Scientific Advisory Board brings decades of experience in dermatology, skin cancer, genomics, and biotech innovation to help us redefine the way we test and treat skin cancer.

» Meet Our Scientific Advisors

Our Board of Directors

Our Board of Directors has diverse experience in biotechnology, diagnostics, therapeutics, medical and other industries, bringing decades of experience to the team. 

» Meet Our Board of Directors

Our Scientific Advisory Board

Our Scientific Advisory Board brings decades of experience in dermatology, skin cancer, genomics, and biotech innovation to help us redefine the way we test and treat skin cancer.

» Meet Our Scientific Advisors

Meet the DermTech Melanoma Test

This simple smart sticker gives your doctor data on your mole’s genomic makeup at the RNA level, showing signs of melanoma earlier and more accurately than a traditional biopsy care pathway.

 

» See How It Works

In Development

DermTech: Carcinome

Find the presence of non-melanoma skin cancers at the genomic level. The Carcinome test is currently in development.

DermTech: Carcinome

Find the presence of non-melanoma skin cancers at the genomic level. The Carcinome test is currently in development.

DermTech: LuminateSM

Identify UV damage at the genomic level. The LuminateSM test is currently in development.

DermTech: LuminateSM

Identify UV damage at the genomic level. The LuminateSM test is currently in development.

Partners in Innovation

 

We consult, collaborate and work with leaders in the world of genomics, medicine, biotechnology, wellness, and more.

 

» Meet Our Partners

DermTech in the News

Read how DermTech is changing the world of dermatology.

Make a Difference,
Join the Team

Want to help change the world of dermatology? DermTech is currently hiring for the following positions.

» View Opportunities